RxDoctor Payments Data

Mark Reynolds

Psychiatry · Moraine, OHNPI 1992857437

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $13,452 of the $16,259 with a category attached, or 82.7%. Alkermes, Inc. accounts for 78.0% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $8,461 and has fallen 98.5% since, to $123 in 2025. Among psychiatry clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,259in general payments, 2019–2025

Across 106 payments — averaging $153.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$13K
  • Otsuka America Pharmaceutical, Inc.$2K
  • Ironshore Pharmaceuticals Inc.$307
  • Johnson & Johnson$155
  • Sunovion Pharmaceuticals Inc.$129
  • Corium, LLC$122
  • plus $651 from 14 others

What the payments were for

  • Speaking & faculty fees$13,45283%
  • Travel & lodging$3662%
  • Food & beverage$2,44115%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,259 in reported general payments places this provider in the 90th percentile of 1,119 psychiatry providers in Ohio.

See all psychiatry providers in Ohio →

Other psychiatry in Moraine

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →